oxford international biomedical ventures limitedEstimated Valuation
£0
Pomanda estimates the enterprise value of OXFORD INTERNATIONAL BIOMEDICAL VENTURES LIMITED at £0 based on a Turnover of £0 and 5.48x industry multiple (adjusted for size and gross margin).
oxford international biomedical ventures limitedEstimated Valuation
£0
Pomanda estimates the enterprise value of OXFORD INTERNATIONAL BIOMEDICAL VENTURES LIMITED at £0 based on an EBITDA of £0 and a 0x industry multiple (adjusted for size and gross margin).
oxford international biomedical ventures limitedEstimated Valuation
£0
Pomanda estimates the enterprise value of OXFORD INTERNATIONAL BIOMEDICAL VENTURES LIMITED at £0 based on Net Assets of £3 and 0.25x industry multiple (adjusted for liquidity).
Edit your figures and get a professional valuation report.
Oxford International Biomedical Ventures LimitedOverview
Oxford International Biomedical Ventures Limited is a live company located in abingdon, OX14 3DB with a Companies House number of 04451509. It operates in the dormant company sector, SIC Code 99999. Founded in May 2002, it's largest shareholder is
paul pattinson
with a 66.7% stake. Oxford International Biomedical Ventures Limited is a mature,
unknown sized company, Pomanda has estimated its turnover at
£0 with
unknown
growth in recent years.
Oxford International Biomedical Ventures Limited Health Check
There is insufficient data available to calculate a health check for Oxford International Biomedical Ventures Limited. Company Health Check FAQs
Health Rating0out of 5
0 Strong
0 Regular
0 Weak
Size
There is insufficient data available for this Key Performance Indicator!
- - Oxford International Biomedical Ventures Limited
- - Industry AVG
Growth
There is insufficient data available for this Key Performance Indicator!
- - Oxford International Biomedical Ventures Limited
- - Industry AVG
Production
There is insufficient data available for this Key Performance Indicator!
- - Oxford International Biomedical Ventures Limited
- - Industry AVG
Profitability
There is insufficient data available for this Key Performance Indicator!
- - Oxford International Biomedical Ventures Limited
- - Industry AVG
Employees
There is insufficient data available for this Key Performance Indicator!
- - Oxford International Biomedical Ventures Limited
- - Industry AVG
Pay Structure
There is insufficient data available for this Key Performance Indicator!
- - Oxford International Biomedical Ventures Limited
- - Industry AVG
Efficiency
There is insufficient data available for this Key Performance Indicator!
- - Oxford International Biomedical Ventures Limited
- - Industry AVG
Debtor Days
There is insufficient data available for this Key Performance Indicator!
- - Oxford International Biomedical Ventures Limited
- - Industry AVG
Creditor Days
There is insufficient data available for this Key Performance Indicator!
- - Oxford International Biomedical Ventures Limited
- - Industry AVG
Stock Days
There is insufficient data available for this Key Performance Indicator!
- - Oxford International Biomedical Ventures Limited
- - Industry AVG
Cash Balance
There is insufficient data available for this Key Performance Indicator!
- - Oxford International Biomedical Ventures Limited
- - Industry AVG
Debt Level
There is insufficient data available for this Key Performance Indicator!
- - Oxford International Biomedical Ventures Limited
- - Industry AVG
OXFORD INTERNATIONAL BIOMEDICAL VENTURES LIMITED financials
EXPORT
Oxford International Biomedical Ventures Limited's latest turnover from May 2023 is estimated at 0 and the company has net assets of £3. According to their latest financial statements, we estimate that Oxford International Biomedical Ventures Limited has no employees and maintains cash reserves of 0 as reported in the balance sheet.
Data source:Companies House, Pomanda Estimates
May 2023
May 2022
May 2021
May 2020
May 2019
May 2018
May 2017
May 2016
May 2015
May 2014
May 2013
May 2012
May 2011
May 2010
Turnover
Other Income Or Grants
Cost Of Sales
Gross Profit
Admin Expenses
Operating Profit
Interest Payable
Interest Receivable
Pre-Tax Profit
Tax
Profit After Tax
Dividends Paid
Retained Profit
Employee Costs
Number Of Employees
EBITDA*
* Earnings Before Interest, Tax, Depreciation and Amortisation
May 2023
May 2022
May 2021
May 2020
May 2019
May 2018
May 2017
May 2016
May 2015
May 2014
May 2013
May 2012
May 2011
May 2010
Tangible Assets
Intangible Assets
Investments & Other
3
3
3
3
3
Debtors (Due After 1 year)
Total Fixed Assets
3
3
3
3
3
Stock & work in progress
Trade Debtors
Group Debtors
Misc Debtors
Cash
misc current assets
total current assets
total assets
3
3
3
3
3
Bank overdraft
Bank loan
Trade Creditors
Group/Directors Accounts
other short term finances
hp & lease commitments
other current liabilities
total current liabilities
loans
hp & lease commitments
Accruals and Deferred Income
other liabilities
provisions
total long term liabilities
total liabilities
net assets
3
3
3
3
3
total shareholders funds
3
3
3
3
3
May 2023
May 2022
May 2021
May 2020
May 2019
May 2018
May 2017
May 2016
May 2015
May 2014
May 2013
May 2012
May 2011
May 2010
Operating Activities
Operating Profit
Depreciation
Amortisation
Tax
Stock
Debtors
Creditors
Accruals and Deferred Income
Deferred Taxes & Provisions
Cash flow from operations
Investing Activities
capital expenditure
Change in Investments
3
cash flow from investments
-3
Financing Activities
Bank loans
Group/Directors Accounts
Other Short Term Loans
Long term loans
Hire Purchase and Lease Commitments
other long term liabilities
share issue
3
interest
cash flow from financing
3
cash and cash equivalents
cash
overdraft
change in cash
oxford international biomedical ventures limited Credit Report and Business Information
Very Low Risk70 - 100
Low Risk50 - 70
Moderate Risk30 - 50
High Risk20 - 30
Very High Risk0 - 20
Get a comprehensive credit check for oxford international biomedical ventures limited. Get real-time insights into oxford international biomedical ventures limited's credit score, group structure and payment trends.
Oxford International Biomedical Ventures Limited Competitor Analysis
Perform a competitor analysis for oxford international biomedical ventures limited by selecting its closest rivals, whether from the ACTIVITIES OF EXTRATERRITORIAL ORGANISATIONS AND BODIES sector, other mature companies, companies in OX14 area or any other competitors across 12 key performance metrics.
oxford international biomedical ventures limited Ownership
OXFORD INTERNATIONAL BIOMEDICAL VENTURES LIMITED group structure
Oxford International Biomedical Ventures Limited has no subsidiary companies.
Ultimate parent company
OXFORD INTERNATIONAL BIOMEDICAL VENTURES LIMITED
04451509
OXFORD INTERNATIONAL BIOMEDICAL VENTURES LIMITED Shareholders
The largest shareholders in Oxford International Biomedical Ventures Limited include Paul Pattinson and Charles Alexander Pasternak.
paul pattinson
66.67%
charles alexander pasternak
33.33%
oxford international biomedical ventures limited directors
Oxford International Biomedical Ventures Limited currently has 2 directors.
The longest serving directors include
Mr Paul Pattinson (Jul 2002) and
Mr Charles Pasternak (Jul 2002).
Turnover, or revenue, is the amount of sales generated by a company within the financial year.
Balance Sheet
May 2023
net assets
3
0%
total assets
3
0%
cash
0
0%
net assets
Total assets minus all liabilities
Similar Companies
Similar companies unavailable for this selection
oxford international biomedical ventures limited company details
company number
04451509
Type
Private limited with Share Capital
industry
99999 - Dormant Company
incorporation date
May 2002
age
23
incorporated
UK
ultimate parent company
None
accounts
Dormant
last accounts submitted
May 2023
previous names
4mation 37 limited (June 2002)
accountant
-
auditor
-
address
oibc culham innovation centre, d5 culham science centre, abingdon, oxfordshire, OX14 3DB
Bank
-
Legal Advisor
-
oxford international biomedical ventures limited Charges & Mortgages
A charge, or mortgage, refers to the rights a company gives to a lender in return for a loan, often in the form of security given over business assets.
We did not find charges/mortgages relating to oxford international biomedical ventures limited.
oxford international biomedical ventures limited Capital Raised & Share Issues BETA
When a company issues new shares, e.g. to new investors following a funding round, it is required to notify Companies House within one month of making an allotment of shares.
Click to start generating capital raising & share issue transactions for OXFORD INTERNATIONAL BIOMEDICAL VENTURES LIMITED. This can take several minutes, an email will notify you when this has completed.
oxford international biomedical ventures limitedCompanies House Filings - See Documents
